The Fly on the Wall: Athersys Publishes Study on Increasing Survival of Organ Transplants With Stem Cells

Athersys (ATHX) is a clinical stage based biopharmaceutical company with an exponentially growing pipeline and an array of products in therapeutics to treat significant and life-threatening diseases.

Read more »